Association between the N-acetylation genetic polymorphism and bronchial asthma
Article first published online: 17 DEC 2002
British Journal of Clinical Pharmacology
Volume 54, Issue 6, pages 671–674, December 2002
How to Cite
Nacak, M., Aynacioglu, A. S., Filiz, A., Cascorbi, I., Erdal, M. E., Yilmaz, N., Ekinci, E. and Roots, I. (2002), Association between the N-acetylation genetic polymorphism and bronchial asthma. British Journal of Clinical Pharmacology, 54: 671–674. doi: 10.1046/j.1365-2125.2002.01670.x
- Issue published online: 17 DEC 2002
- Article first published online: 17 DEC 2002
- Received 29 April 2002, accepted 26 June 2002.
- molecular genetics;
Aims Since polymorphic N-acetyltransferase 2 (NAT2) has been suggested as a susceptibility factor for atopic diseases, the study was undertaken to investigate whether an association exists between acetylation polymorphism and asthma patients with atopy.
Methods The frequencies of NAT2 alleles and genotypes were determined by PCR/RFLP in a total of 210 asthma patients (extrinsic (n = 108) and intrinsic (n = 102) asthmatics) and 240 control subjects. Presence of the NAT2*4 (wild-type) allele defined a NAT2 genotype as rapid and combinations of mutant alleles NAT2*5 A, *5B, *5C, *6 A, and *7B as slow.
Results Genotypes coding for slow acetylation were detected in 70.4, 58.4 and 58.3% of extrinsic asthmatics, but intrinsic asthmatics and control subjects, respectively. The frequency of slow acetylators was higher among extrinsic asthmatics than intrinsic asthmatics, this difference did not reach statistical significance (odds ratio 1.02, 95% confidence interval 0.64, 1.63, P = 0.085). However, we found a relatively moderate, but significantly higher, increased frequency of slow acetylators among extrinsic asthma patients compared with control subjects (odds ratio 1.70, 95% confidence interval 1.04, 2.76, P = 0.042).
Conclusions This study shows an association between acetylation polymorphism and susceptibility to extrinsic asthma, but not to intrinsic asthma, suggesting a minor role of the NAT2 polymorphism in the development of atopic asthma.